Hi-Tech Pharmacal Co. (HITK) Misses Q3 EPS by 28c
Tweet
Share
E-mailGet Alerts HITK Hot Sheet
Price: $43.49 --0%
Financial Fact:
Income tax expense: 3.96M
Today's EPS Names:
SQZB, ARDS, MDRX, More
Financial Fact:
Income tax expense: 3.96M
Today's EPS Names:
SQZB, ARDS, MDRX, More
Join SI Premium – FREE
Hi-Tech Pharmacal Co. (NASDAQ: HITK) reported Q3 EPS of $0.43, $0.28 worse than the analyst estimate of $0.71. Revenue for the quarter came in at $64.33 million versus the consensus estimate of $60.45 million.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
For earnings history and earnings-related data on Hi-Tech Pharmacal Co. (HITK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- DA Davidson Assumes Knife River Corp. (KNF) at Buy
- Dick's Sporting Goods (DKS) Misses Q2 EPS by 25c, Offers Guidance
- Global Payments (GPN) PT Raised to $95 at Truist Securities
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
